By Aaron Miller-
Donald Trump on Thursday signed an executive order to move cannabis out of the most restrictive drug category, but stop short of making marijuana legal on a federal level.
Cannabis is classified as a Schedule I drug, the most restrictive federal category that includes heroin and LSD. Under this change, it moves to a Schedule III drug, putting it in the same group as some common prescription painkillers such as Tylenol with codeine.
AD: Capeesh Restaurant
The placement of marijuana in Schedule III would align it with certain prescription pain medications, while keeping recreational use illegal at the federal level. The change would still need to go through the Drug Enforcement Administration’s (DEA) formal rule-making process.
The White House emphasised that this change makes it easier for scientists to study marijuana, especially around its potential to treat chronic pain and other conditions
“The executive order the President will sign today is focused on increasing medical research for medical marijuana and CBD,” a senior administration official told ABC News ahead the signing.
AD: Oysterian Sea Food Restaurant And Bar
“The President is very focused on the potential medical benefits, and he has directed a common sense approach that will automatically start working to improve the medical marijuana and CBD research to better inform patients and doctors. That’s the primary goal,” the official added.
The order directs Attorney General Pam Bondi to expedite the completion of the process of rescheduling marijuana, according to a senior White House official, who outlined the order on a background call with reporters on Thursday.
“Nearly one in four U.S. adults have chronic pain; more than one in three U.S. seniors and six of 10 people that use medical marijuana report doing so to manage pain,” the official said.
“I’m pleased to announce that I will be signing an Executive Order to reschedule marijuana from a Schedule I to a Schedule III controlled substance with legitimate medical uses,” the president said from the Oval Office.
“This reclassification order will make it far easier to conduct marijuana-related medical research, allowing us to study benefits, potential dangers and future treatments,” Trump added. “It’s going to have a tremendously positive impact.”
The action allows for a pilot program that reimburses Medicare patients for products containing CBD, a widely used cannabis-derived compound that does not produce a high.
Marijuana would be shifted from Schedule I, a category that includes heroin, to Schedule III, which also includes ketamine. The executive order would not legalize marijuana as some states have done, and would not change how law enforcement agencies handle marijuana-related arrests.
The reclassification could make scientific research easier as well as ease burdens on legal cannabis businesses by reducing strict federal tax penalties and improving access to banking services.
The order directs the Department of Health and Human Services (HHS) to develop “research methods and models utilizing real-world evidence” to study the long-term health effects of medical marijuana and hemp-derived cannabinoid products.
It also states the White House will work with Congress to expand access to appropriate full-spectrum CBD products while restricting products that pose serious health risks, citing a current lack of FDA approval. According to the order, one in five US adults and nearly 15% of seniors reported using CBD in the past year.
Marijuana’s designation as a highly dangerous and addictive substance has been widely criticized. Moving it to a different category reflects a federal acknowledgment that cannabis has recognized medical benefits and a lower risk of abuse than previously classified. Trump’s order does not affect recreational marijuana nor does it include any changes to criminal justice laws.
Pew research suggests that 57% of Americans think cannabis should be legal for medical and recreational purposes, while 32% think it should be legal for medical use only.
Paul Armentano, deputy director of the National Organization for the Reform of Marijuana Laws (Norml), said that the order “validates the experiences of tens of millions of Americans, as well as those of tens of thousands of physicians, who have long recognized that cannabis possesses legitimate medical utility”.
Armentano added: “while such a move potentially provides some benefits to patients, and veterans especially, it still falls well short of the changes necessary to bring federal marijuana policy into the 21st century.”
AD: Heritage And Restaurant Lounge Bar